(Q55473763)

12 July 2018

title

Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors. (English)

1 reference

12 July 2018

author name string

Sally L Dennis

1

1 reference

12 July 2018

Shehnaaz S M Manji

2

1 reference

12 July 2018

Darryl P Carrington

3

1 reference

12 July 2018

Deborah L Scarcella

4

1 reference

12 July 2018

David M Ashley

5

1 reference

12 July 2018

Peter J Smith

6

1 reference

12 July 2018

Elizabeth M Algar

7

1 reference

12 July 2018

language of work or name

English

0 references

publication date

1 February 2002

1 reference

12 July 2018

International Journal of Cancer

published in

1 reference

12 July 2018

volume

97

1 reference

12 July 2018

issue

5

1 reference

12 July 2018

page(s)

713-715

1 reference

12 July 2018

Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product

cites work

1 reference

Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1.

21 January 2018

1 reference

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

21 January 2018

1 reference

The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin

21 January 2018

1 reference

E-cadherin is a WT1 target gene

21 January 2018

1 reference

WT-1 is required for early kidney development

21 January 2018

1 reference

Zinc finger point mutations within the WT1 gene in Wilms tumor patients

21 January 2018

1 reference

Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor

21 January 2018

1 reference

The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma

21 January 2018

1 reference

A clinical overview of WT1 gene mutations

21 January 2018

1 reference

The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo.

21 January 2018

1 reference

Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens.

21 January 2018

1 reference

Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour.

21 January 2018

1 reference

Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program

21 January 2018

1 reference

Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF).

21 January 2018

1 reference

Overexpression of murine WT1 + / + and - / - isoforms has no effect on chemoresistance but delays differentiation in the K562 leukemia cell line

21 January 2018

1 reference

Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth

21 January 2018

1 reference

Mutation analysis of the WT1 gene in sporadic childhood leukaemia

21 January 2018

1 reference

Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10106

1 reference

12 July 2018

PubMed ID

11807803

1 reference

12 July 2018